SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission, clinical trial finds

by

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher rates of remission compared with calorie restriction alone, finds a trial published by The BMJ.

Leave A Comment

Your email address will not be published. Required fields are marked *